tq05105
Small moleculeexperimental
Clinical trial activity
14 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
11
Phase 2
7
Phase 3
1
Phase 4
0
Earliest trial started Nov 20, 2018 (NCT04339400)
Timeline
Indications
Mechanism of action
- Rho-associated protein kinase 1INHIBITOR
ROCK1 inhibitor
- Jak1 proteinINHIBITOR
JAK1 inhibitor
- Tyrosine-protein kinase JAK2INHIBITOR
JAK2 inhibitor
- Rho-associated protein kinase 2INHIBITOR
ROCK2 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)c(N)n1- Mol. weight
- 321.39 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314485 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06682169 | Phase 3 | Nov 30, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06598956 | Phase 1 | Oct 15, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06245941 | Phase 1/Phase 2 (Phase 2) | May 13, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06300320 | Phase 2 | May 7, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT07293390 | Phase 1 | Mar 18, 2024 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06122831 | Phase 1/Phase 2 (Phase 2) | Dec 12, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06024915 | Phase 1 | Sep 30, 2023 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT06388759 | Phase 1 | Aug 1, 2022 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT05020652 | Phase 2 | Nov 11, 2021 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT04941404 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2021 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT05982106 | Phase 1 | Jul 19, 2021 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT04944043 | Phase 1/Phase 2 (Phase 2) | Jun 28, 2021 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT04326348 | Phase 1 | Apr 30, 2020 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
| NCT04339400 | Phase 1 | Nov 20, 2018 | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | For profit | 14 | 14 | 3 | 2018 |
1 organizations
Page 1 / 1